TARS vs. AAPL
Compare and contrast key facts about Tarsus Pharmaceuticals, Inc. (TARS) and Apple Inc (AAPL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TARS or AAPL.
Correlation
The correlation between TARS and AAPL is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TARS vs. AAPL - Performance Comparison
Loading data...
Key characteristics
TARS:
0.23
AAPL:
0.37
TARS:
0.75
AAPL:
0.83
TARS:
1.09
AAPL:
1.12
TARS:
0.24
AAPL:
0.42
TARS:
0.71
AAPL:
1.40
TARS:
18.76%
AAPL:
10.06%
TARS:
56.12%
AAPL:
32.89%
TARS:
-77.67%
AAPL:
-81.80%
TARS:
-23.60%
AAPL:
-18.17%
Fundamentals
TARS:
$1.80B
AAPL:
$3.18T
TARS:
-$2.70
AAPL:
$6.41
TARS:
7.71
AAPL:
7.94
TARS:
5.26
AAPL:
47.61
TARS:
$233.67M
AAPL:
$400.37B
TARS:
$217.29M
AAPL:
$186.70B
TARS:
-$98.27M
AAPL:
$138.87B
Returns By Period
In the year-to-date period, TARS achieves a -21.44% return, which is significantly lower than AAPL's -15.36% return.
TARS
-21.44%
-11.44%
-6.75%
12.99%
N/A
N/A
AAPL
-15.36%
4.74%
-7.12%
11.97%
23.19%
21.97%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TARS vs. AAPL — Risk-Adjusted Performance Rank
TARS
AAPL
TARS vs. AAPL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Tarsus Pharmaceuticals, Inc. (TARS) and Apple Inc (AAPL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
TARS vs. AAPL - Dividend Comparison
TARS has not paid dividends to shareholders, while AAPL's dividend yield for the trailing twelve months is around 0.48%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TARS Tarsus Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AAPL Apple Inc | 0.48% | 0.40% | 0.49% | 0.70% | 0.49% | 0.61% | 1.04% | 1.79% | 1.45% | 1.93% | 1.93% | 1.67% |
Drawdowns
TARS vs. AAPL - Drawdown Comparison
The maximum TARS drawdown since its inception was -77.67%, smaller than the maximum AAPL drawdown of -81.80%. Use the drawdown chart below to compare losses from any high point for TARS and AAPL. For additional features, visit the drawdowns tool.
Loading data...
Volatility
TARS vs. AAPL - Volatility Comparison
Tarsus Pharmaceuticals, Inc. (TARS) has a higher volatility of 12.79% compared to Apple Inc (AAPL) at 10.62%. This indicates that TARS's price experiences larger fluctuations and is considered to be riskier than AAPL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
TARS vs. AAPL - Financials Comparison
This section allows you to compare key financial metrics between Tarsus Pharmaceuticals, Inc. and Apple Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TARS vs. AAPL - Profitability Comparison
TARS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Tarsus Pharmaceuticals, Inc. reported a gross profit of 73.12M and revenue of 78.34M. Therefore, the gross margin over that period was 93.4%.
AAPL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Apple Inc reported a gross profit of 44.87B and revenue of 95.36B. Therefore, the gross margin over that period was 47.1%.
TARS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Tarsus Pharmaceuticals, Inc. reported an operating income of -26.28M and revenue of 78.34M, resulting in an operating margin of -33.6%.
AAPL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Apple Inc reported an operating income of 29.59B and revenue of 95.36B, resulting in an operating margin of 31.0%.
TARS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Tarsus Pharmaceuticals, Inc. reported a net income of -25.12M and revenue of 78.34M, resulting in a net margin of -32.1%.
AAPL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Apple Inc reported a net income of 24.78B and revenue of 95.36B, resulting in a net margin of 26.0%.